Pharmstandard   Report issue

For profit Phase 4
Founded: Moscow Russian Federation (2003)
Status: No NME R&D (2003)

Organization Overview

First Clinical Trial
2011
NCT01651663
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now